BioCatalystWatch
MCRBWorkspace / MCRB / OverviewCompany library
Seres Therapeutics, Inc. logo

Seres Therapeutics, Inc.

Seres Therapeutics, Inc. (MCRB)

Website

Price
Market cap
Next catalystFDA engagement in Q1 2027, after study-design submissionSER-155 — planned irEC prophylaxis study · Regulatory meetingSEC filing ↗
Cash

Chart & Events

Candle interval

Core Clinical

SER-155

Upcoming / outlook

  • Timing and evidence

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

SER-155

Upcoming / outlook

  • Timing and evidence

Other pipelines

SER-155

SER-155

SER-155

SER-603

SER-603

SER-428

PreINDP2P3FilingApproved
Upcoming / outlook

Partner / License out

History / paused

SER-155

PreINDP1P2P3FilingApproved
SER-155

PreINDP1P2P3FilingApproved

Approved

PreINDP1P2P3FilingApproved
SER-155

PreINDP1P3FilingApproved
Upcoming / outlook

Financial position

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Source and basis

Source and basis

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

MCRB PR & News

PR & News

MCRB SEC archive